Added to YB: 2023-11-24
Pitch date: 2023-11-24
ATRA:US [bullish]
Atara Biotherapeutics, Inc.
+4.32%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the United States and the United Kingdom.
Market Cap
$49.5M
Pitch Price
$17.25
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.34
P/E
-0.38
EV/Sales
0.32
Sector
Biotechnology
Category
N/A
Show full summary:
Atara Biotherapeutics Inc ATRA:US
A summary for this pitch has not been created yet.
Read full article (0 min)